drugset / Trial / NCT03633747
Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma
NaSingle-groupOpen-labelTreatment
Summary
Hepatic hemangioma is one of the most common benign tumor of the liver. Although the overall prognosis is good, active interventions are still needed in high-risk patients. Without specific drugs, the main treatment methods include surgical treatments, interventional therapies and radiotherapies. Effective medical treatments are needed urgently. Propranolol has achieved good results in infantile Facial/hepatic hemangioma, and shows some effectiveness in adult hemangioma. Here, investigators intend to evaluate the therapeutic effect of propranolol in adult hepatic hemangioma.
Timeline
- Start
- 2018-07-01
- Primary completion
- 2020-08-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propranolol | Small molecule | 1.5 mg/kg | Oral |